Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Naloxone PK/PD Study
NCT05876572Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, open-label, single-arm trial of naloxone in opioid overdose, sponsored by Johns Hopkins University. Primary endpoint: Detection of Plasma Naloxone Concentration. Planned start Aug 2024; status: withdrawn.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT05876572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05876572.